These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

483 related items for PubMed ID: 19374532

  • 1. Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells.
    Taetz S, Bochot A, Surace C, Arpicco S, Renoir JM, Schaefer UF, Marsaud V, Kerdine-Roemer S, Lehr CM, Fattal E.
    Oligonucleotides; 2009 Jun; 19(2):103-16. PubMed ID: 19374532
    [Abstract] [Full Text] [Related]

  • 2. Hyaluronic acid-bearing lipoplexes: physico-chemical characterization and in vitro targeting of the CD44 receptor.
    Dufaÿ Wojcicki A, Hillaireau H, Nascimento TL, Arpicco S, Taverna M, Ribes S, Bourge M, Nicolas V, Bochot A, Vauthier C, Tsapis N, Fattal E.
    J Control Release; 2012 Sep 28; 162(3):545-52. PubMed ID: 22820451
    [Abstract] [Full Text] [Related]

  • 3. Lipoplexes targeting the CD44 hyaluronic acid receptor for efficient transfection of breast cancer cells.
    Surace C, Arpicco S, Dufaÿ-Wojcicki A, Marsaud V, Bouclier C, Clay D, Cattel L, Renoir JM, Fattal E.
    Mol Pharm; 2009 Sep 28; 6(4):1062-73. PubMed ID: 19413341
    [Abstract] [Full Text] [Related]

  • 4. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
    Hattori Y, Nakamura A, Arai S, Kawano K, Maitani Y, Yonemochi E.
    J Liposome Res; 2015 Sep 28; 25(4):279-86. PubMed ID: 25543847
    [Abstract] [Full Text] [Related]

  • 5. Supramolecular Organization and siRNA Binding of Hyaluronic Acid-Coated Lipoplexes for Targeted Delivery to the CD44 Receptor.
    Nascimento TL, Hillaireau H, Noiray M, Bourgaux C, Arpicco S, Pehau-Arnaudet G, Taverna M, Cosco D, Tsapis N, Fattal E.
    Langmuir; 2015 Oct 20; 31(41):11186-94. PubMed ID: 26375384
    [Abstract] [Full Text] [Related]

  • 6. The synergy between structural stability and DNA-binding controls the antibody production in EPC/DOTAP/DOPE liposomes and DOTAP/DOPE lipoplexes.
    de la Torre LG, Rosada RS, Trombone AP, Frantz FG, Coelho-Castelo AA, Silva CL, Santana MH.
    Colloids Surf B Biointerfaces; 2009 Oct 15; 73(2):175-84. PubMed ID: 19540734
    [Abstract] [Full Text] [Related]

  • 7. Effect of hyaluronic acid-binding to lipoplexes on intravitreal drug delivery for retinal gene therapy.
    Martens TF, Peynshaert K, Nascimento TL, Fattal E, Karlstetter M, Langmann T, Picaud S, Demeester J, De Smedt SC, Remaut K, Braeckmans K.
    Eur J Pharm Sci; 2017 May 30; 103():27-35. PubMed ID: 28223236
    [Abstract] [Full Text] [Related]

  • 8. DOTAP functionalizing single-walled carbon nanotubes as non-viral vectors for efficient intracellular siRNA delivery.
    Li H, Hao Y, Wang N, Wang L, Jia S, Wang Y, Yang L, Zhang Y, Zhang Z.
    Drug Deliv; 2016 May 30; 23(3):840-8. PubMed ID: 24892622
    [Abstract] [Full Text] [Related]

  • 9. DOTAP/DOPE ratio and cell type determine transfection efficiency with DOTAP-liposomes.
    Kim BK, Hwang GB, Seu YB, Choi JS, Jin KS, Doh KO.
    Biochim Biophys Acta; 2015 Oct 30; 1848(10 Pt A):1996-2001. PubMed ID: 26112463
    [Abstract] [Full Text] [Related]

  • 10. Hyaluronic acid-conjugated lipoplexes for targeted delivery of siRNA in a murine metastatic lung cancer model.
    Leite Nascimento T, Hillaireau H, Vergnaud J, Rivano M, Deloménie C, Courilleau D, Arpicco S, Suk JS, Hanes J, Fattal E.
    Int J Pharm; 2016 Nov 30; 514(1):103-111. PubMed ID: 27863652
    [Abstract] [Full Text] [Related]

  • 11. Efficient telomerase inhibition in human non-small cell lung cancer cells by liposomal delivery of 2'-O-methyl-RNA.
    Beisner J, Dong M, Taetz S, Piotrowska K, Kleideiter E, Friedel G, Schaefer U, Lehr CM, Klotz U, Mürdter TE.
    J Pharm Sci; 2009 May 30; 98(5):1765-74. PubMed ID: 18803262
    [Abstract] [Full Text] [Related]

  • 12. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
    Cardoso AL, Simões S, de Almeida LP, Pelisek J, Culmsee C, Wagner E, Pedroso de Lima MC.
    J Gene Med; 2007 Mar 30; 9(3):170-83. PubMed ID: 17351968
    [Abstract] [Full Text] [Related]

  • 13. Influence of plasmid DNA topology on the transfection properties of DOTAP/DOPE lipoplexes.
    Remaut K, Sanders NN, Fayazpour F, Demeester J, De Smedt SC.
    J Control Release; 2006 Oct 27; 115(3):335-43. PubMed ID: 17010468
    [Abstract] [Full Text] [Related]

  • 14. Factors affecting DNA binding and stability of association to cationic liposomes.
    Even-Chen S, Cohen R, Barenholz Y.
    Chem Phys Lipids; 2012 May 27; 165(4):414-23. PubMed ID: 22715503
    [Abstract] [Full Text] [Related]

  • 15. Lipoplexes versus nanoparticles: pDNA/siRNA delivery.
    Khurana B, Goyal AK, Budhiraja A, Aora D, Vyas SP.
    Drug Deliv; 2013 Feb 27; 20(2):57-64. PubMed ID: 23537464
    [Abstract] [Full Text] [Related]

  • 16. Enhanced cellular uptake and gene silencing activity of siRNA using temperature-responsive polymer-modified liposome.
    Wang J, Ayano E, Maitani Y, Kanazawa H.
    Int J Pharm; 2017 May 15; 523(1):217-228. PubMed ID: 28330734
    [Abstract] [Full Text] [Related]

  • 17. Enhanced transfection efficiency and reduced cytotoxicity of novel lipid-polymer hybrid nanoplexes.
    Jain S, Kumar S, Agrawal AK, Thanki K, Banerjee UC.
    Mol Pharm; 2013 Jun 03; 10(6):2416-25. PubMed ID: 23597269
    [Abstract] [Full Text] [Related]

  • 18. Effect of "helper lipid" on lipoplex electrostatics.
    Hirsch-Lerner D, Zhang M, Eliyahu H, Ferrari ME, Wheeler CJ, Barenholz Y.
    Biochim Biophys Acta; 2005 Aug 15; 1714(2):71-84. PubMed ID: 16051183
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Liposomal siRNA delivery.
    Hughes J, Yadava P, Mesaros R.
    Methods Mol Biol; 2010 Aug 15; 605():445-59. PubMed ID: 20072900
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.